These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 21725130)

  • 1. Transient coronary aneurysm formation after Nevo™ stent implantation versus persistent coronary aneurysm after Cypher Select™ stent implantation.
    Christiansen EH; Lassen JF; Jensen LO
    J Invasive Cardiol; 2011 Jul; 23(7):E158-60. PubMed ID: 21725130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymer-free sirolimus- and probucol-eluting versus new generation zotarolimus-eluting stents in coronary artery disease: the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting versus Zotarolimus-eluting Stents (ISAR-TEST 5) trial.
    Massberg S; Byrne RA; Kastrati A; Schulz S; Pache J; Hausleiter J; Ibrahim T; Fusaro M; Ott I; Schömig A; Laugwitz KL; Mehilli J;
    Circulation; 2011 Aug; 124(5):624-32. PubMed ID: 21768546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary pseudoaneurysm in a non-polymer drug-eluting stent: a rare entity.
    Kapoor A; Batra A; Kumar S; Pandey S; Agarwal SK; Sinha N
    Asian Cardiovasc Thorac Ann; 2011 Dec; 19(6):407-10. PubMed ID: 22160410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).
    Kandzari DE; Mauri L; Popma JJ; Turco MA; Gurbel PA; Fitzgerald PJ; Leon MB
    JACC Cardiovasc Interv; 2011 May; 4(5):543-50. PubMed ID: 21596327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late stent thrombosis associated with coronary aneurysm formation after sirolimus-eluting stent implantation.
    Aziz S; Morris JL; Perry RA
    J Invasive Cardiol; 2007 Apr; 19(4):E96-8. PubMed ID: 17404416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary artery aneurysm after implantation of an endothelial progenitor cell capturing stent.
    Rychter M; Radomski M; Sukiennik A; Serafin Z; Koziński M; Kubica J
    Kardiol Pol; 2012; 70(6):641-4. PubMed ID: 22718389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple coronary artery aneurysm formation one year and four years after sirolimus-eluting coronary stent implantation.
    Ovünç K; Yorgun H; Ozer N
    Cardiovasc Revasc Med; 2009; 10(4):252-4. PubMed ID: 19815173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Very late stent thrombosis associated with multiple stent fractures and peri-stent aneurysm formation after sirolimus-eluting stent implantation.
    Lee SE; John SH; Lim JH; Rhew JY
    Circ J; 2008 Jul; 72(7):1201-4. PubMed ID: 18577836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).
    Eisenstein EL; Leon MB; Kandzari DE; Mauri L; Edwards R; Kong DF; Cowper PA; Anstrom KJ;
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1199-207. PubMed ID: 20129546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
    Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
    Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents.
    Byrne RA; Kastrati A; Tiroch K; Schulz S; Pache J; Pinieck S; Massberg S; Seyfarth M; Laugwitz KL; Birkmeier KA; Schömig A; Mehilli J;
    J Am Coll Cardiol; 2010 Jun; 55(23):2536-43. PubMed ID: 20417052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IVUS-guided management of late stent malaposition with peri-stent restenosis with coronary artery aneurysm following drug-eluting stent implantation (paxlitaxel-eluting stent).
    Lanjewar CP; Sharma A; Sheth T
    J Invasive Cardiol; 2009 May; 21(5):E87-90. PubMed ID: 19411733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chinese "Firebird" brand sirolimus-eluting stent fracture.
    Hu W; Zhang DD; Gu J
    J Invasive Cardiol; 2009 Dec; 21(12):E242-4. PubMed ID: 19966375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covered-stent treatment of coronary aneurysm after drug-eluting stent placement: case report and literature review.
    Bajaj S; Parikh R; Hamdan A; Bikkina M
    Tex Heart Inst J; 2010; 37(4):449-54. PubMed ID: 20844620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical and angiographic outcomes after implantation of sirolimus-eluting stents with a "modified mini-crush" technique in coronary bifurcation lesions.
    Yang HM; Tahk SJ; Woo SI; Lim HS; Choi BJ; Choi SY; Yoon MH; Park JS; Zheng M; Hwang GS; Kang SJ; Shin JH
    Catheter Cardiovasc Interv; 2009 Jul; 74(1):76-84. PubMed ID: 19360861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Coronary artery aneurysm one year and five months after sirolimus-eluting stent placement].
    Abreu L; Meireles GC; Forte AA; Sumita M; Hayashi J; Solano J
    Arq Bras Cardiol; 2005 Nov; 85(5):340-2. PubMed ID: 16358151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiographic outcomes with biodegradable polymer and permanent polymer drug-eluting stents.
    Kufner S; Massberg S; Dommasch M; Byrne RA; Tiroch K; Ranftl S; Fusaro M; Schömig A; Kastrati A; Mehilli J;
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):161-6. PubMed ID: 21400652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiographic spontaneous pseudo-resolution of a coronary artery aneurysm after implantation of a sirolimus-eluting stent.
    Choi YW; Lim HS; Tahk SJ; Yoon MH; Yang HM; Jin XJ
    Korean J Intern Med; 2016 Sep; 31(5):987-90. PubMed ID: 26813572
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of angiographic and IVUS follow-up between the two different drug-eluting stents implanted simultaneously in the same individuals.
    Xiang D; Yi S; Ruan Y; Gong Z; Hong C; Qiu J
    J Invasive Cardiol; 2012 Aug; 24(8):374-8. PubMed ID: 22865306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.